Targeting the mitochondria to augment myocardial protection

Current Opinion in Pharmacology

Volumn 8, Issue 2, 2008, Pages 160-165

  Schwartz, Daniel R ^a   Sack, Michael N ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ANTIOXIDANT; BIGUANIDE DERIVATIVE; GUANIDINOPROPIONIC ACID; MITOQ; NITRITE; REACTIVE OXYGEN METABOLITE; RESVERATROL; UNCLASSIFIED DRUG;

CALCIUM HOMEOSTASIS; CALORIC RESTRICTION; CELL STRESS; DEGENERATIVE DISEASE; DNA REPAIR; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG TARGETING; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HOMEOSTASIS; NONHUMAN; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; STRESS;

EID: 40649125236     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2007.12.008     Document Type: Review

References (63)

1. T.J. Schulz K. Zarse A. Voigt N. Urban M. Birringer M. Ristow Glucose restriction extend Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress Cell Metab 6 2007 280 293
2. D.T. Johnson R.A. Harris S. French P.V. Blair J. You K. Bemis M. Wang R.S. Balaban Tissue heterogeneity of the mammalian mitochondrial proteome Am J Physiol Cell Physiol 292 2007 C689 C697
3. C.J. McLeod I. Pagel M.N. Sack The mitochondrial biogenesis regulatory program in cardiac adaptation to ischemia—a putative target for therapeutic intervention Trends Cardiovasc Med 15 2005 118 123
4. B.N. Finck D.P. Kelly Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease Circulation 115 2007 2540 2548
5. Z. Arany H. He J. Lin K. Hoyer C. Handschin O. Toka F. Ahmad T. Matsui S. Chin P.H. Wu Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle Cell Metab 1 2005 259 271
6. C.J. Lelliott G. Medina-Gomez N. Petrovic A. Kis H.M. Feldmann M. Bjursell N. Parker K. Curtis M. Campbell P. Hu Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance PLoS Biol 4 2006 e369
7. Z. Arany M. Novikov S. Chin Y. Ma A. Rosenzweig B.M. Spiegelman Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha Proc Natl Acad Sci U S A 103 2006 10086 10091
8. I. Luptak J.A. Balschi Y. Xing T.C. Leone D.P. Kelly R. Tian Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization Circulation 112 2005 2339 2346
9. L. Cheng G. Ding Q. Qin Y. Huang W. Lewis N. He R.M. Evans M.D. Schneider F.A. Brako Y. Xiao Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy Nat Med 10 2004 1245 1250
10. G. Ding M. Fu Q. Qin W. Lewis H.W. Kim T. Fukai M. Bacanamwo Y.E. Chen M.D. Schneider D.J. Mangelsdorf Cardiac peroxisome proliferator-activated receptor gamma is essential in protecting cardiomyocytes from oxidative damage Cardiovasc Res 76 2007 269 279
11. M. Ikeuchi H. Matsusaka D. Kang S. Matsushima T. Ide T. Kubota T. Fujiwara N. Hamasaki A. Takeshita K. Sunagawa Overexpression of mitochondrial transcription factor a ameliorates mitochondrial deficiencies and cardiac failure after myocardial infarction Circulation 112 2005 683 690
12. J.J. Lehman P.M. Barger A. Kovacs J.E. Saffitz D.M. Medeiros D.P. Kelly Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis J Clin Invest 106 2000 847 856
13. N. Sambandam D. Morabito C. Wagg B.N. Finck D.P. Kelly G.D. Lopaschuk Chronic activation of PPARalpha is detrimental to cardiac recovery after ischemia Am J Physiol Heart Circ Physiol 290 2006 H87 H95
14. S.A. Detmer D.C. Chan Functions and dysfunctions of mitochondrial dynamics Nat Rev Mol Cell Biol 8 2007 870 879
15. D.J. Hausenloy L. Scorrano Targeting cell death Clin Pharmacol Ther 82 2007 370 373
16. D.A. Sinclair Toward a unified theory of caloric restriction and longevity regulation Mech Ageing Dev 126 2005 987 1002
17. G. Lopez-Lluch N. Hunt B. Jones M. Zhu H. Jamieson S. Hilmer M.V. Cascajo J. Allard D.K. Ingram P. Navas Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency Proc Natl Acad Sci U S A 103 2006 1768 1773
18. E. Nisoli C. Tonello A. Cardile V. Cozzi R. Bracale L. Tedesco S. Falcone A. Valerio O. Cantoni E. Clementi Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS Science 310 2005 314 317
19. K. Shinmura K. Tamaki R. Bolli Short-term caloric restriction improves ischemic tolerance independent of opening of ATP-sensitive K+ channels in both young and aged hearts J Mol Cell Cardiol 39 2005 285 296
20. M.C. Haigis L.P. Guarente Mammalian sirtuins—emerging roles in physiology, aging, and calorie restriction Genes Dev 20 2006 2913 2921
21. R.R. Alcendor L.A. Kirshenbaum S. Imai S.F. Vatner J. Sadoshima Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes Circ Res 95 2004 971 980
22. R.R. Alcendor S. Gao P. Zhai D. Zablocki E. Holle X. Yu B. Tian T. Wagner S.F. Vatner J. Sadoshima Sirt1 regulates aging and resistance to oxidative stress in the heart Circ Res 100 2007 1512 1521
23. D.M. Yellon D.J. Hausenloy Myocardial reperfusion injury N Engl J Med 357 2007 1121 1135
24. Q. Chen C.L. Hoppel E.J. Lesnefsky Blockade of electron transport before cardiac ischemia with the reversible inhibitor amobarbital protects rat heart mitochondria J Pharmacol Exp Ther 316 2006 200 207
25. C.J. McLeod A. Aziz R.F. Hoyt Jr. J.P. McCoy Jr. M.N. Sack Uncoupling proteins 2 and 3 function in concert to augment tolerance to cardiac ischemia J Biol Chem 280 2005 33470 33476
26. S.M. Nadtochiy A.J. Tompkins P.S. Brookes Different mechanisms of mitochondrial proton leak in ischaemia/reperfusion injury and preconditioning: implications for pathology and cardioprotection Biochem J 395 2006 611 618
27. N. Yamashita M. Nishida S. Hoshida T. Kuzuya M. Hori N. Taniguchi T. Kamada M. Tada Induction of manganese superoxide dismutase in rat cardiac myocytes increases tolerance to hypoxia 24 hours after preconditioning J Clin Invest 94 1994 2193 2199
28. M. Lagouge C. Argmann Z. Gerhart-Hines H. Meziane C. Lerin F. Daussin N. Messadeq J. Milne P. Lambert P. Elliott Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha Cell 127 2006 1109 1122
29. J.A. Baur K.J. Pearson N.L. Price H.A. Jamieson C. Lerin A. Kalra V.V. Prabhu J.S. Allard G. Lopez-Lluch K. Lewis Resveratrol improves health and survival of mice on a high-calorie diet Nature 444 2006 337 342
30. B. Dasgupta J. Milbrandt Resveratrol stimulates AMP kinase activity in neurons Proc Natl Acad Sci U S A 104 2007 7217 7222
31. J.A. Baur D.A. Sinclair Therapeutic potential of resveratrol: the in vivo evidence Nat Rev Drug Discov 5 2006 493 506
32. S. Das V.K. Alagappan D. Bagchi H.S. Sharma N. Maulik D.K. Das Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart Vascul Pharmacol 42 2005 281 289
33. M. Thirunavukkarasu S.V. Penumathsa S. Koneru B. Juhasz L. Zhan H. Otani D. Bagchi D.K. Das N. Maulik Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase Free Radic Biol Med 43 2007 720 729
34. S.V. Penumathsa M. Thirunavukkarasu S. Koneru B. Juhasz L. Zhan R. Pant V.P. Menon H. Otani N. Maulik Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat J Mol Cell Cardiol 42 2007 508 516
35. S.S. Goh O.L. Woodman S. Pepe A.H. Cao C. Qin R.H. Ritchie The red wine antioxidant resveratrol prevents cardiomyocyte injury following ischemia-reperfusion via multiple sites and mechanisms Antioxid Redox Signal 9 2007 101 113
36. J.G. Wood B. Rogina S. Lavu K. Howitz S.L. Helfand M. Tatar D. Sinclair Sirtuin activators mimic caloric restriction and delay ageing in metazoans Nature 430 2004 686 689
37. R.M. Reznick G.I. Shulman The role of AMP-activated protein kinase in mitochondrial biogenesis J Physiol 574 2006 33 39
38. R.M. Reznick H. Zong J. Li K. Morino I.K. Moore H.J. Yu Z.X. Liu J. Dong K.J. Mustard S.A. Hawley Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis Cell Metab 5 2007 151 156
39. D.A. Hood I. Irrcher V. Ljubicic A.M. Joseph Coordination of metabolic plasticity in skeletal muscle J Exp Biol 209 2006 2265 2275
40. W.J. Lee M. Kim H.S. Park H.S. Kim M.J. Jeon K.S. Oh E.H. Koh J.C. Won M.S. Kim G.T. Oh AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1 Biochem Biophys Res Commun 340 2006 291 295
41. S. Jager C. Handschin J. St-Pierre B.M. Spiegelman AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha Proc Natl Acad Sci U S A 104 2007 12017 12022
42. M. Zhou B.Z. Lin S. Coughlin G. Vallega P.F. Pilch UCP-3 expression in skeletal muscle: effects of exercise, hypoxia, and AMP-activated protein kinase Am J Physiol Endocrinol Metab 279 2000 E622 E629
43. S.B. Jorgensen J.T. Treebak B. Viollet P. Schjerling S. Vaulont J.F. Wojtaszewski E.A. Richter Role of AMPKalpha2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle Am J Physiol Endocrinol Metab 292 2007 E331 E339
44. S.J. Baron J. Li R.R. Russell 3rd D. Neumann E.J. Miller R. Tuerk T. Wallimann R.L. Hurley L.A. Witters L.H. Young Dual mechanisms regulating AMPK kinase action in the ischemic heart Circ Res 96 2005 337 345
45. R.R. Russell 3rd J. Li D.L. Coven M. Pypaert C. Zechner M. Palmeri F.J. Giordano J. Mu M.J. Birnbaum L.H. Young AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury J Clin Invest 114 2004 495 503
46. Y. Athea B. Viollet P. Mateo D. Rousseau M. Novotova A. Garnier S. Vaulont J.R. Wilding A. Grynberg V. Veksler AMP-activated protein kinase alpha2 deficiency affects cardiac cardiolipin homeostasis and mitochondrial function Diabetes 56 2007 786 794
47. D.G. Hardie AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy Nat Rev Mol Cell Biol 8 2007 774 785
48. L.H. Young J. Li S.J. Baron R.R. Russell AMP-activated protein kinase: a key stress signaling pathway in the heart Trends Cardiovasc Med 15 2005 110 118
49. D.G. Hardie AMP-activated protein kinase as a drug target Annu Rev Pharmacol Toxicol 47 2007 185 210
50. M. Suwa T. Egashira H. Nakano H. Sasaki S. Kumagai Metformin increases the PGC-1alpha protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo J Appl Physiol 101 2006 1685 1692
51. L. Wilson-Fritch S. Nicoloro M. Chouinard M.A. Lazar P.C. Chui J. Leszyk J. Straubhaar M.P. Czech S. Corvera Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone J Clin Invest 114 2004 1281 1289
52. R.J. Legtenberg R.J. Houston B. Oeseburg P. Smits Metformin improves cardiac functional recovery after ischemia in rats Horm Metab Res 34 2002 182 185
53. T.L. Yue Tl J. Chen W. Bao P.K. Narayanan A. Bril W. Jiang P.G. Lysko J.L. Gu R. Boyce D.M. Zimmerman In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone Circulation 104 2001 2588 2594
54. M.N. Sack Mitochondrial depolarization and the role of uncoupling proteins in ischemia tolerance Cardiovasc Res 72 2006 210 219
55. E.J. Lesnefsky Q. Chen S. Moghaddas M.O. Hassan B. Tandler C.L. Hoppel Blockade of electron transport during ischemia protects cardiac mitochondria J Biol Chem 279 2004 47961 47967
56. S.P. Jones R. Bolli The ubiquitous role of nitric oxide in cardioprotection J Mol Cell Cardiol 40 2006 16 23
57. S. Shiva M.N. Sack J.J. Greer M. Duranski L.A. Ringwood L. Burwell X. Wang P.H. MacArthur A. Shoja N. Raghavachari Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer J Exp Med 204 2007 2089 2102
58. M.T. Gladwin A.N. Schechter D.B. Kim-Shapiro R.P. Patel N. Hogg S. Shiva R.O. Cannon 3rd M. Kelm D.A. Wink M.G. Espey The emerging biology of the nitrite anion Nat Chem Biol 1 2005 308 314
59. M.R. Duranski J.J. Greer A. Dejam S. Jaganmohan N. Hogg W. Langston R.P. Patel S.F. Yet X. Wang C.G. Kevil Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver J Clin Invest 115 2005 1232 1240
60. V.M. Victor M. Rocha Targeting antioxidants to mitochondria: a potential new therapeutic strategy for cardiovascular diseases Curr Pharm Des 13 2007 845 863
61. M.F. Ross G.F. Kelso F.H. Blaikie A.M. James H.M. Cocheme A. Filipovska T. Da Ros T.R. Hurd R.A. Smith M.P. Murphy Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology Biochemistry (Mosc) 70 2005 222 230
62. V.J. Adlam J.C. Harrison C.M. Porteous A.M. James R.A. Smith M.P. Murphy I.A. Sammut Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury FASEB J 19 2005 1088 1095
63. R.A. Smith C.M. Porteous A.M. Gane M.P. Murphy Delivery of bioactive molecules to mitochondria in vivo Proc Natl Acad Sci U S A 100 2003 5407 5412